AMS X

3D Printing Unpeeled: Screen Printing Drugs, Repair Process for Marines & PCL Drug Release

Formnext
IMTS

Share this Article

Contract development and manufacturing organization (CDMO) Adare Pharma Solutions, is partnering with Laxxon Medical. The CDMO will use Screen-Printed Innovative Drug (SPID) to make oral dosage forms where they hope to do things with drug release, multiple APIs, make drugs that are easier to swallow and even help with taste masking. The company aims to buy two printers; one has been installed in Milan, and the other will be in Ohio. 

The United States Marine Corps has worked with Naval Air Systems Command’s (NAVAIR) Additive Manufacturing (AM) Integrated Product Team (IPT) on a Suitable Substitute Engineering Change Proposal (ECP) for a 3D printed part replacing a conventional one. The part is a Bell UH-1Y rescue hoist chain guard cover. It is hoped that in future this process will be used to make more non critical parts faster. The part ordering process cost $1,700 whereas normally it would cost $300,000.

Researchers Zheru Ma, Yao Zhao, Zhe Xu and Yao Zhang from the Department of Bone and Joint Surgery, Orthopedic Center of the First Hospital of Jilin University, have published a paper on using PCL and antibiotics to make a controlled release solution that stops biofilm formation and allows for controlled antibiotic release on titanium implants. 



Share this Article


Recent News

Beehive Industries Buys Two Nikon NXGs

After 17 Years at 3D Systems, Katie Weimer Is Betting on Regenerative Breast Tissue



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

The Longevity Economy Needs a Factory

Longevity has become one of the biggest stories in healthcare. Every week seems to add a new announcement about an anti-aging therapy, an AI-powered drug discovery platform, or a startup...

New University of Miami Facility Brings Bioprinting Closer to Clinical Reality

The University of Miami‘s Miller School of Medicine has opened a new bioprinting facility that is already being used to create living tissues, patient-specific implants, and advanced drug delivery systems....

Researchers Combine AI and Bioprinting to Create Tiny Blood Vessel Networks

If 2026 has a theme in bioprinting, it may be blood vessels. Researchers can already print incredibly sophisticated tissues. The harder part is keeping those tissues alive. Without a network...

3D Printing Financials: Capital Raises, Portfolio Reshuffling, and Market Pressure

It’s been busy for publicly traded 3D printing companies, with new stock offerings, dealmaking, and investor updates showing how companies are working to strengthen their financial positions. Xometry raised $225...